Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

RVPH

RVPH News

Newswire

11:40

Reviva Pharmaceuticals shares rise 10.21% intraday after analysts give "Moderate Buy" rating.

10:52

Reviva shares jump 10.01% intraday following CEO appointment of Nasser Al-Mutairi with three-decade industry expertise.

08:49

Reviva:D. Boral Capital Raises PT to $2, Maintains Buy Rating

05:15

Reviva shares surge 11.80% premarket as positive customer reviews highlight product efficacy and demand.

17:57

Reviva Pharmaceuticals Aims for Q2 2026 NDA Submission for Schizophrenia Treatment

View More

About RVPH

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More